Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.

Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W 3rd, Tonsgard JH, Welling DB, Widemann B, Yohay K, Giovannini M.

Clin Cancer Res. 2009 Aug 15;15(16):5032-9. doi: 10.1158/1078-0432.CCR-08-3011. Epub 2009 Aug 11.

2.

Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.

Ammoun S, Flaiz C, Ristic N, Schuldt J, Hanemann CO.

Cancer Res. 2008 Jul 1;68(13):5236-45. doi: 10.1158/0008-5472.CAN-07-5849.

3.

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.

Plotkin SR, Singh MA, O'Donnell CC, Harris GJ, McClatchey AI, Halpin C.

Nat Clin Pract Oncol. 2008 Aug;5(8):487-91. doi: 10.1038/ncponc1157. Epub 2008 Jun 17.

PMID:
18560388
4.

What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers N, Huson SM, Wallace AJ.

J Neurosurg. 2008 Jan;108(1):92-6. doi: 10.3171/JNS/2008/108/01/0092.

PMID:
18173316
5.

Magic but treatable? Tumours due to loss of merlin.

Hanemann CO.

Brain. 2008 Mar;131(Pt 3):606-15. Epub 2007 Oct 16. Review.

PMID:
17940085
6.

Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?

Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A.

Clin Genet. 2007 Apr;71(4):354-8.

PMID:
17470137
7.
8.

Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings.

Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP.

Hum Mutat. 2007 Jan;28(1):1-12.

PMID:
16983642
9.

The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.

Baser ME; Contributors to the International NF2 Mutation Database..

Hum Mutat. 2006 Apr;27(4):297-306. Review.

PMID:
16521120
10.

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME.

J Med Genet. 2006 Apr;43(4):289-94. Epub 2005 Sep 9. Review.

11.

Management of the patient and family with neurofibromatosis 2: a consensus conference statement.

Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R.

Br J Neurosurg. 2005 Feb;19(1):5-12. Review.

PMID:
16147576
13.

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG.

J Med Genet. 2005 Jul;42(7):540-6. Review.

14.

Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?

Dow G, Biggs N, Evans G, Gillespie J, Ramsden R, King A.

J Neurosurg Spine. 2005 May;2(5):574-9.

PMID:
15945431
15.
16.

Screening for large mutations of the NF2 gene.

Kluwe L, Nygren AO, Errami A, Heinrich B, Matthies C, Tatagiba M, Mautner V.

Genes Chromosomes Cancer. 2005 Apr;42(4):384-91.

PMID:
15645494
17.

Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.

Lomas J, Bello MJ, Arjona D, Alonso ME, Martinez-Glez V, Lopez-Marin I, Amiñoso C, de Campos JM, Isla A, Vaquero J, Rey JA.

Genes Chromosomes Cancer. 2005 Mar;42(3):314-9.

PMID:
15609345
18.

Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.

Tsilchorozidou T, Menko FH, Lalloo F, Kidd A, De Silva R, Thomas H, Smith P, Malcolmson A, Dore J, Madan K, Brown A, Yovos JG, Tsaligopoulos M, Vogiatzis N, Baser ME, Wallace AJ, Evans DG.

J Med Genet. 2004 Jul;41(7):529-34. Review. No abstract available.

19.

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.

Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE, Ramsden RT, Evans DG.

Am J Hum Genet. 2004 Aug;75(2):231-9. Epub 2004 Jun 9.

20.

CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas.

Gonzalez-Gomez P, Bello MJ, Alonso ME, Lomas J, Arjona D, Campos JM, Vaquero J, Isla A, Lassaletta L, Gutierrez M, Sarasa JL, Rey JA.

Clin Cancer Res. 2003 Nov 15;9(15):5601-6.

Supplemental Content

Support Center